# Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/activity-and-safety-of-brigatinib-in-alk-rearranged-non-small-cell-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Scott Gettinger,Lyudmila Bazhenova,Corey J. Langer,Ravi Salgia,Kathryn A. Gold,Rafael Rosell,Alice T. Shaw,Glen J. Weiss,Meera Tugnait,Narayana I. Narasimhan,David J. Dorer,David Kerstein,Victor M. Rivera,Timothy Piers Clackson,Frank G. Haluska,David Ross Camidge |
| Citations | 352 |
| DOI | 10.1016/s1470-2045(16)30392-8 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2551769647 |
| PMID | 27836716 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Ravi Salgia](https://scholariq.org/researchers/ravi-salgia/)
- [Lyudmila Bazhenova](https://scholariq.org/researchers/lyudmila-bazhenova/)
- [Kathryn A. Gold](https://scholariq.org/researchers/kathryn-a-gold/)
- [Alice T. Shaw](https://scholariq.org/researchers/alice-t-shaw/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.